asSeq
asSeq performs allele-specific analysis of RNA-seq and ChIP-seq next-generation sequencing data by integrating allele-specific expression (ASE) and total read count (TReC) for cis- and trans-eQTL mapping.
Key Features:
- Allele-Specific Expression (ASE) Analysis: Leverages RNA-seq and integrates total read count (TReC) with ASE measurements to resolve allele-specific expression and distinguish cis- and trans-eQTL.
- Enhanced eQTL Mapping: Employs a direct modeling approach using discrete distributions for TReC data, providing higher statistical power compared to two-step normalization followed by linear regression.
- Cost-Effective Experimental Design: Combines TReC and ASE data to enable reduced sample sizes with increased sequencing depth per sample while maintaining statistical power for cis-eQTL studies.
- Versatility Across Data Types: Extends the framework beyond RNA-seq to other sequencing datasets such as ChIP-seq and supports single-gene association-based eQTL mapping with groundwork for linkage-based and multi-marker/multi-gene studies.
Scientific Applications:
- Genetic Basis of Gene Expression: Identifies genetic variants that influence gene expression levels by integrating ASE and TReC measurements.
- Disease Association Studies: Pinpoints specific alleles associated with differential gene expression to inform genetic investigations of disease mechanisms.
- Functional Genomics Research: Dissects cis- and trans-eQTLs to clarify regulatory networks underlying genome function.
Methodology:
asSeq implements a unified statistical framework that models TReC with discrete distributions and integrates ASE data to directly infer cis- and trans-eQTLs, in contrast to two-step normalization followed by linear regression.
Topics
Details
- Tool Type:
- library
- Operating Systems:
- Linux, Windows, Mac
- Added:
- 8/3/2017
- Last Updated:
- 11/25/2024
Operations
Publications
Sun W. A Statistical Framework for eQTL Mapping Using RNA‐seq Data. Biometrics. 2011;68(1):1-11. doi:10.1111/j.1541-0420.2011.01654.x. PMID:21838806. PMCID:PMC3218220.